Erector spinae plane block versus quadratus lumborum block in pediatric patients undergoing surgical repair of developmental dislocation (dysplasia) of the hip; a prospective randomized controlled trial
Not Applicable
Not yet recruiting
- Conditions
- perioperative analgesia for DDHAnaesthesia
- Registration Number
- PACTR202003578252979
- Lead Sponsor
- Tanta University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
age 1- 6 years
either gender
ASA I-II
undergoing unilateral elective surgical repair of DDH
Exclusion Criteria
parental refusal
allergy to the study drug
any contraindication to regional anesthesia e.g. infection at injection site or coagulopathy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of erector spinae plane block and quadratus lumborum block in pediatric postoperative pain management?
How does the efficacy of erector spinae plane block compare to quadratus lumborum block and standard-of-care analgesia in developmental dislocation of the hip surgery?
What are the primary clinical endpoints in PACTR202003578252979 comparing ESPB and QLB for pediatric hip dysplasia surgery?
Which biomarkers correlate with prolonged analgesia duration in erector spinae plane or quadratus lumborum blocks for developmental dislocation of the hip repair?
Are there combination approaches involving ESPB or QLB with other regional anesthetics to enhance analgesia in pediatric hip dysplasia surgical repair?